Category: Body Systems
Your hormones are not the problem. The system that regulates them is. Here is how the thyroid, cortisol and sex-hormone axes actually interact, and where plant medicine genuinely fits.
Category: Body Systems | Reading time: ~17 min | Level: Intermediate
Hormones get blamed for everything. Bad skin, low energy, weight that refuses to shift, moods that do not match the circumstances, periods that arrive like a physiological emergency. In wellness culture, the word "hormonal" has become a catch-all for something being wrong without knowing what. The frustration behind that is real. The framing, in most cases, is not.
Hormones are not the problem. Hormones are the messages. The problem, when one exists, lives in the system that generates, regulates, transports, and clears those messages: the endocrine system. Understanding the difference between a hormonal symptom and a hormonal system problem is the first step toward addressing either effectively.
This article covers the hormonal system from the ground up: the three major axes governing hormonal output, how cortisol disrupts sex hormone production, how the thyroid connects to nearly every other hormonal system, what oestrogen dominance actually is as a physiological state, and which plants have the most clearly characterised mechanisms for hormonal support. Not adaptogens in general, not "hormone-balancing herbs" as a marketing category. Specific compounds, named mechanisms, and the clinical evidence behind them.
The endocrine system is the body's hormonal communication network: a collection of glands, organs, and tissues that produce, release, and respond to chemical messengers called hormones. Unlike the nervous system, which transmits signals in milliseconds via electrical impulses, the endocrine system operates on longer timescales, shaping physiology over hours, days, and cycles.
The hypothalamus sits at the top of the hierarchy. This small brain structure receives input from virtually every part of the brain and body and translates that input into hormonal signals governing the pituitary gland below it. The pituitary, often called the master gland, receives hypothalamic signals and sends its own hormones to peripheral glands: the adrenal glands, the thyroid, the ovaries, and the testes.
This creates three major hormonal axes that govern the majority of what people mean when they talk about their hormones.
The HPA axis (hypothalamic-pituitary-adrenal) governs the stress response and cortisol production. It is the axis most disrupted by modern life and the one most likely to pull the other two axes out of alignment when it fails. For a detailed breakdown of the HPA axis, see the Nervous System pillar article.
The HPT axis (hypothalamic-pituitary-thyroid) governs metabolic rate, body temperature, energy production, mood, and cognition through regulation of thyroid hormones. When this axis is disrupted, the effect registers across nearly every other hormonal system.
The HPG axis (hypothalamic-pituitary-gonadal) governs reproduction and the production of oestrogen, progesterone, and testosterone in both sexes. Its output is cyclical in women and continuous in men, and it is profoundly sensitive to signals from both the HPA and HPT axes.
These three axes are not isolated. They share signalling infrastructure, precursor compounds, and receptor populations. Disruption in one consistently produces disruption in the others, which is why people with hormonal complaints so rarely have a single clean problem and so often present with a cluster of interconnected ones.
The thyroid gland produces two primary hormones: thyroxine (T4) and triiodothyronine (T3). T4 is the storage form, relatively inactive until converted to T3 in the liver and peripheral tissues. This conversion requires adequate selenium, zinc, and iron as cofactors. T3 is the biologically active hormone that enters cells and drives metabolic rate.
The HPT axis operates through a familiar negative feedback loop. The hypothalamus releases thyrotropin-releasing hormone (TRH), which signals the pituitary to release thyroid-stimulating hormone (TSH). TSH signals the thyroid to produce T4. As T4 and T3 levels rise, they suppress TRH and TSH production, keeping thyroid hormones within a narrow functional range.
Disruption occurs at multiple points along this axis. Chronic stress and elevated cortisol directly suppress TSH production and inhibit the T4-to-T3 conversion enzyme, reducing active T3 availability even when TSH levels appear normal on standard testing. Elevated cortisol also promotes the production of reverse T3 (rT3), an inactive form that competes with T3 for receptor binding without activating metabolism. This is the physiological mechanism behind the low-energy, weight-resistant, cognitively foggy pattern seen in chronically stressed individuals whose thyroid panel appears technically normal.
This HPA-HPT crosstalk explains why treating thyroid symptoms in isolation, without addressing the cortisol load driving T3 suppression, produces limited and inconsistent results in a significant proportion of patients.
The relationship between the HPA axis and the HPG axis is direct and biochemically specific. Cortisol, oestrogen, progesterone, and testosterone are all synthesised from a shared precursor called pregnenolone, itself derived from cholesterol. When the adrenal axis demands sustained cortisol output under chronic stress, pregnenolone is preferentially diverted toward the cortisol synthesis pathway.
The consequence is reduced substrate availability for sex hormone synthesis. In women, this most commonly manifests as blunted progesterone production in the luteal phase, disrupted cycle length and regularity, or worsened premenstrual symptoms as the oestrogen-to-progesterone ratio shifts. In men, sustained cortisol elevation correlates with suppressed testosterone output, reduced libido, and blunted physical recovery.
This mechanism, sometimes called the pregnenolone steal, is not controversial in endocrinology. It is one of the clearest demonstrations that stress management is not separate from hormonal health. For many women experiencing premenstrual difficulties or cycle irregularity, the upstream driver is HPA axis dysregulation rather than an intrinsic problem with ovarian function.
Oestrogen dominance is one of the most used and most misunderstood terms in hormonal wellness. It does not necessarily mean oestrogen levels are high in absolute terms. It means oestrogen is high relative to progesterone, creating a ratio imbalance that drives a specific cluster of symptoms: heavy or painful periods, breast tenderness, bloating, irritability, poor sleep in the second half of the cycle, and fat accumulation around the hips and thighs.
This ratio can shift through several distinct mechanisms. First, progesterone production may be inadequate, particularly in the luteal phase, resulting from the pregnenolone diversion described above, from short or anovulatory cycles, or from an under-functioning corpus luteum after ovulation. Second, oestrogen may be excessive because it is not being adequately cleared. The liver processes oestrogen through two phases of metabolism: phase one converts oestrogens into intermediate metabolites, and phase two conjugates those metabolites for excretion via the gut. If phase two is sluggish due to poor liver function, nutritional deficiencies, or high toxic load, unconjugated oestrogens re-enter circulation rather than being excreted.
A third driver is gut-related. The gut microbiome contains bacteria that produce an enzyme called beta-glucuronidase. This enzyme deconjugates oestrogen that has already been processed by the liver and prepared for excretion, allowing it to be reabsorbed from the gut into circulation. A dysbiotic gut with elevated beta-glucuronidase activity can meaningfully increase oestrogen recirculation independent of production levels.
Fourth is xenoestrogen exposure: synthetic compounds in plastics (particularly bisphenol A), conventional cosmetics, pesticide residues, and some industrial chemicals that bind to oestrogen receptors and amplify oestrogenic signalling. The endocrine-disrupting effects of xenoestrogens are documented in peer-reviewed literature and are relevant to real-world hormonal load.
The insulin connection is particularly important for women with PCOS. Insulin resistance creates a hormonal environment that directly stimulates ovarian androgen production. High insulin levels stimulate luteinising hormone (LH) receptors on ovarian theca cells, driving excess androgen synthesis. Excess androgens suppress sex hormone-binding globulin (SHBG), raising free testosterone and driving the acne, hirsutism, and cycle disruption characteristic of hyperandrogenic PCOS. Addressing insulin resistance is frequently more clinically impactful in this population than targeting androgens directly.
Several botanicals have documented, mechanism-specific effects on hormonal regulation. The ones worth knowing are distinguished by clinical evidence, not marketing claims.
Vitex agnus-castus (Chaste Tree Berry)
Vitex is the most evidence-supported botanical for luteal phase support and progesterone deficiency. Its mechanism is dopaminergic rather than oestrogenic. Compounds in Vitex bind to dopamine D2 receptors in the pituitary, suppressing prolactin release. Elevated prolactin inhibits progesterone synthesis. By reducing prolactin, Vitex creates conditions for improved luteal progesterone output. This is not a phytoestrogen effect and Vitex should not be categorised as one.
A landmark double-blind RCT by Schellenberg published in the British Medical Journal (2001) enrolled 178 women with PMS and administered a standardised Vitex extract versus placebo for three menstrual cycles. The Vitex group showed statistically significant improvements across irritability, mood alteration, headache, and breast fullness. A 2013 systematic review confirmed the effect across multiple trials.
DIM (Diindolylmethane)
DIM is formed from indole-3-carbinol, which is present in brassica vegetables including broccoli, Brussels sprouts, and cauliflower. In the gut, indole-3-carbinol converts to DIM during digestion. DIM shifts oestrogen metabolism toward the 2-hydroxyoestrone pathway (a less oestrogenically active metabolite) and away from the 16-alpha-hydroxyoestrone pathway (a more oestrogenically active metabolite). This makes it clinically relevant in oestrogen dominance and conditions driven by elevated oestrogenic activity.
Black Cohosh (Actaea racemosa)
Black cohosh is frequently mischaracterised as a phytoestrogen. The evidence does not support this classification. Current research indicates its mechanisms involve serotonin and dopamine receptor modulation rather than direct oestrogenic activity. It does not bind to oestrogen receptors in breast tissue and does not behave pharmacologically as an oestrogen. Multiple RCTs and a Cochrane review have established its efficacy for perimenopausal symptoms including hot flushes, sleep disruption, and mood instability.
Spearmint (Mentha spicata)
For hyperandrogenic presentations including PCOS-associated acne and hirsutism, spearmint has documented anti-androgenic activity. A 2010 RCT by Grant published in Phytotherapy Research enrolled 42 women with PCOS and administered spearmint tea twice daily for 30 days. Significant reductions in free testosterone and luteinising hormone were observed alongside self-reported improvements in hirsutism scores.
Milk Thistle (Silybum marianum)
Milk thistle's silymarin complex supports liver phase two detoxification, which is central to oestrogen clearance. It is frequently included in oestrogen dominance protocols specifically for this hepatoprotective and phase two-supporting role rather than for any direct hormonal activity.
It is a loose umbrella term for symptoms arising when the endocrine feedback loops are dysregulated, too much or too little of a hormone, or poor signalling and clearance. The useful question is which axis (thyroid, adrenal/cortisol, or sex hormones) is driving it.
It usually means estrogen is high relative to progesterone, often because progesterone has dropped faster, not necessarily because estrogen is abnormally high. Stress, gut health and how efficiently you clear estrogen all influence it.
Chronic stress keeps cortisol elevated, and because cortisol and the sex hormones share the precursor pregnenolone, sustained stress can divert resources away from progesterone and testosterone, the "pregnenolone steal." Cortisol is upstream of the whole system.
Specific plants have real, targeted effects, vitex on the pituitary, ovarian signal, spearmint on androgens, DIM on estrogen metabolism, but they support regulation rather than supplying hormones. In diagnosed conditions they belong alongside medical care, not instead of it.
Testing helps, but timing and interpretation matter enormously (especially across the menstrual cycle), and a single snapshot can mislead. Pair testing with symptom patterns and, ideally, a clinician who reads them in context.
"Normal" reference ranges are wide, and a single timed draw can miss cyclical shifts or signalling problems that lab values do not capture. Symptoms that persist despite normal numbers often point to dysregulation in the feedback loops or clearance pathways rather than a single out-of-range hormone, which is exactly why this guide treats it as a system.
Cortisol/adrenal, almost always, because it sits upstream of the others. If chronic stress is keeping cortisol high, addressing thyroid or sex hormones alone tends to underperform. Stabilise the stress axis (see the nervous system guide) and the downstream picture often improves.
They do different jobs, vitex nudges the pituitary signal that supports progesterone, DIM supports healthier estrogen metabolism. The right one depends on whether your pattern is low progesterone or estrogen clearance, which is why this is best matched to your profile rather than guessed. Remy or a practitioner can help pinpoint it.
This needs professional input, herbs like vitex act on the same pituitary, ovarian signalling that hormonal contraception and HRT override, so combining them can be counterproductive or unpredictable. Do not stack them without talking to the prescriber who manages your medication.